143 related articles for article (PubMed ID: 10949653)
21. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
[TBL] [Abstract][Full Text] [Related]
22. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
[TBL] [Abstract][Full Text] [Related]
23. Scaffolding protein Gab2 mediates differentiation signaling downstream of Fms receptor tyrosine kinase.
Liu Y; Jenkins B; Shin JL; Rohrschneider LR
Mol Cell Biol; 2001 May; 21(9):3047-56. PubMed ID: 11287610
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine kinase signalling pathways.
Pawson T
Princess Takamatsu Symp; 1994; 24():303-22. PubMed ID: 8983084
[TBL] [Abstract][Full Text] [Related]
25. Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction.
Li C; Friedman JM
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9677-82. PubMed ID: 10449753
[TBL] [Abstract][Full Text] [Related]
26. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
Frearson JA; Alexander DR
J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
[TBL] [Abstract][Full Text] [Related]
27. Receptor tyrosine kinase signaling in vascular development.
Merenmies J; Parada LF; Henkemeyer M
Cell Growth Differ; 1997 Jan; 8(1):3-10. PubMed ID: 8993829
[No Abstract] [Full Text] [Related]
28. A novel function for the protein tyrosine phosphatase Shp2 during lung branching morphogenesis.
Tefft D; De Langhe SP; Del Moral PM; Sala F; Shi W; Bellusci S; Warburton D
Dev Biol; 2005 Jun; 282(2):422-31. PubMed ID: 15950607
[TBL] [Abstract][Full Text] [Related]
29. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation.
Sato TN; Tozawa Y; Deutsch U; Wolburg-Buchholz K; Fujiwara Y; Gendron-Maguire M; Gridley T; Wolburg H; Risau W; Qin Y
Nature; 1995 Jul; 376(6535):70-4. PubMed ID: 7596437
[TBL] [Abstract][Full Text] [Related]
30. Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase-dependent mechanism 1.
Mitola S; Brenchio B; Piccinini M; Tertoolen L; Zammataro L; Breier G; Rinaudo MT; den Hertog J; Arese M; Bussolino F
Circ Res; 2006 Jan; 98(1):45-54. PubMed ID: 16339483
[TBL] [Abstract][Full Text] [Related]
31. The SHP-2 tyrosine phosphatase: signaling mechanisms and biological functions.
Qu CK
Cell Res; 2000 Dec; 10(4):279-88. PubMed ID: 11191350
[TBL] [Abstract][Full Text] [Related]
32. Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes.
Nakaoka Y; Nishida K; Fujio Y; Izumi M; Terai K; Oshima Y; Sugiyama S; Matsuda S; Koyasu S; Yamauchi-Takihara K; Hirano T; Kawase I; Hirota H
Circ Res; 2003 Aug; 93(3):221-9. PubMed ID: 12855672
[TBL] [Abstract][Full Text] [Related]
33. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
Fragale A; Tartaglia M; Wu J; Gelb BD
Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
[TBL] [Abstract][Full Text] [Related]
34. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2.
Marrero MB; Venema VJ; Ju H; Eaton DC; Venema RC
Am J Physiol; 1998 Nov; 275(5):C1216-23. PubMed ID: 9814969
[TBL] [Abstract][Full Text] [Related]
35. Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia-reperfusion.
Lin TN; Wang CK; Cheung WM; Hsu CY
J Cereb Blood Flow Metab; 2000 Feb; 20(2):387-95. PubMed ID: 10698077
[TBL] [Abstract][Full Text] [Related]
36. The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration.
Voena C; Conte C; Ambrogio C; Boeri Erba E; Boccalatte F; Mohammed S; Jensen ON; Palestro G; Inghirami G; Chiarle R
Cancer Res; 2007 May; 67(9):4278-86. PubMed ID: 17483340
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory receptors abound?
Cambier JC
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):5993-5. PubMed ID: 9177155
[No Abstract] [Full Text] [Related]
38. Receptor and nonreceptor protein tyrosine phosphatases in the nervous system.
Paul S; Lombroso PJ
Cell Mol Life Sci; 2003 Nov; 60(11):2465-82. PubMed ID: 14625689
[TBL] [Abstract][Full Text] [Related]
39. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
